FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2571282247> ?p ?o ?g. }

• W2571282247 endingPage "592" @default.
• W2571282247 startingPage "586" @default.
• W2571282247 abstract "ObjectivesTo assess the cost-effectiveness of gemcitabine (G), G + 5-fluorouracil, G + capecitabine, G + cisplatin, G + oxaliplatin, G + erlotinib, G + nab-paclitaxel (GnP), and FOLFIRINOX in the treatment of advanced pancreatic cancer from a Canadian public health payer’s perspective, using data from a recently published Bayesian network meta-analysis.MethodsAnalysis was conducted through a three-state Markov model and used data on the progression of disease with treatment from the gemcitabine arms of randomized controlled trials combined with estimates from the network meta-analysis for the newer regimens. Estimates of health care costs were obtained from local providers, and utilities were derived from the literature. The model estimates the effect of treatment regimens on costs and quality-adjusted life-years (QALYs) discounted at 5% per annum.ResultsAt a willingness-to-pay (WTP) threshold of greater than $30,666 per QALY, FOLFIRINOX would be the most optimal regimen. For a WTP threshold of $50,000 per QALY, the probability that FOLFIRINOX would be optimal was 57.8%. There was no price reduction for nab-paclitaxel when GnP was optimal.ConclusionsFrom a Canadian public health payer’s perspective at the present time and drug prices, FOLFIRINOX is the optimal regimen on the basis of the cost-effectiveness criterion. GnP is not cost-effective regardless of the WTP threshold." @default.
• W2571282247 created "2017-01-13" @default.
• W2571282247 creator A5008282524 @default.
• W2571282247 creator A5018567739 @default.
• W2571282247 creator A5028874004 @default.
• W2571282247 creator A5034842369 @default.
• W2571282247 creator A5040161846 @default.
• W2571282247 creator A5044260790 @default.
• W2571282247 creator A5053561819 @default.
• W2571282247 creator A5088066198 @default.
• W2571282247 date "2017-04-01" @default.
• W2571282247 modified "2023-09-22" @default.
• W2571282247 title "Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System" @default.
• W2571282247 cites W1931508686 @default.
• W2571282247 cites W1973173224 @default.
• W2571282247 cites W1982967337 @default.
• W2571282247 cites W1992428774 @default.
• W2571282247 cites W2001644930 @default.
• W2571282247 cites W2034790774 @default.
• W2571282247 cites W2049269081 @default.
• W2571282247 cites W2067379301 @default.
• W2571282247 cites W2083452953 @default.
• W2571282247 cites W2090481758 @default.
• W2571282247 cites W2097642908 @default.
• W2571282247 cites W2101465269 @default.
• W2571282247 cites W2110701556 @default.
• W2571282247 cites W2117105709 @default.
• W2571282247 cites W2132356244 @default.
• W2571282247 cites W2151253787 @default.
• W2571282247 cites W2158134441 @default.
• W2571282247 cites W2158397794 @default.
• W2571282247 cites W2160081417 @default.
• W2571282247 cites W2161817637 @default.
• W2571282247 cites W2165480504 @default.
• W2571282247 doi "https://doi.org/10.1016/j.jval.2016.11.002" @default.
• W2571282247 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28408000" @default.
• W2571282247 hasPublicationYear "2017" @default.
• W2571282247 type Work @default.
• W2571282247 sameAs 2571282247 @default.
• W2571282247 citedByCount "15" @default.
• W2571282247 countsByYear W25712822472017 @default.
• W2571282247 countsByYear W25712822472018 @default.
• W2571282247 countsByYear W25712822472019 @default.
• W2571282247 countsByYear W25712822472021 @default.
• W2571282247 countsByYear W25712822472022 @default.
• W2571282247 countsByYear W25712822472023 @default.
• W2571282247 crossrefType "journal-article" @default.
• W2571282247 hasAuthorship W2571282247A5008282524 @default.
• W2571282247 hasAuthorship W2571282247A5018567739 @default.
• W2571282247 hasAuthorship W2571282247A5028874004 @default.
• W2571282247 hasAuthorship W2571282247A5034842369 @default.
• W2571282247 hasAuthorship W2571282247A5040161846 @default.
• W2571282247 hasAuthorship W2571282247A5044260790 @default.
• W2571282247 hasAuthorship W2571282247A5053561819 @default.
• W2571282247 hasAuthorship W2571282247A5088066198 @default.
• W2571282247 hasBestOaLocation W25712822471 @default.
• W2571282247 hasConcept C112930515 @default.
• W2571282247 hasConcept C121608353 @default.
• W2571282247 hasConcept C126322002 @default.
• W2571282247 hasConcept C138816342 @default.
• W2571282247 hasConcept C143998085 @default.
• W2571282247 hasConcept C159110408 @default.
• W2571282247 hasConcept C162324750 @default.
• W2571282247 hasConcept C175444787 @default.
• W2571282247 hasConcept C2777148230 @default.
• W2571282247 hasConcept C2777364431 @default.
• W2571282247 hasConcept C2777909004 @default.
• W2571282247 hasConcept C2780210213 @default.
• W2571282247 hasConcept C2780258809 @default.
• W2571282247 hasConcept C2780962732 @default.
• W2571282247 hasConcept C2781413609 @default.
• W2571282247 hasConcept C3019080777 @default.
• W2571282247 hasConcept C515549039 @default.
• W2571282247 hasConcept C524218345 @default.
• W2571282247 hasConcept C526805850 @default.
• W2571282247 hasConcept C64332521 @default.
• W2571282247 hasConcept C71924100 @default.
• W2571282247 hasConceptScore W2571282247C112930515 @default.
• W2571282247 hasConceptScore W2571282247C121608353 @default.
• W2571282247 hasConceptScore W2571282247C126322002 @default.
• W2571282247 hasConceptScore W2571282247C138816342 @default.
• W2571282247 hasConceptScore W2571282247C143998085 @default.
• W2571282247 hasConceptScore W2571282247C159110408 @default.
• W2571282247 hasConceptScore W2571282247C162324750 @default.
• W2571282247 hasConceptScore W2571282247C175444787 @default.
• W2571282247 hasConceptScore W2571282247C2777148230 @default.
• W2571282247 hasConceptScore W2571282247C2777364431 @default.
• W2571282247 hasConceptScore W2571282247C2777909004 @default.
• W2571282247 hasConceptScore W2571282247C2780210213 @default.
• W2571282247 hasConceptScore W2571282247C2780258809 @default.
• W2571282247 hasConceptScore W2571282247C2780962732 @default.
• W2571282247 hasConceptScore W2571282247C2781413609 @default.
• W2571282247 hasConceptScore W2571282247C3019080777 @default.
• W2571282247 hasConceptScore W2571282247C515549039 @default.
• W2571282247 hasConceptScore W2571282247C524218345 @default.
• W2571282247 hasConceptScore W2571282247C526805850 @default.
• W2571282247 hasConceptScore W2571282247C64332521 @default.
• W2571282247 hasConceptScore W2571282247C71924100 @default.

• next